| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015730 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070014877 Use of extracts from pelargonium species |
| 01/18/2007 | US20070014840 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription |
| 01/18/2007 | US20070014818 Liquid formulations with high concentration of human growth hormone (HGH) comprising 1,2-propylene glycol |
| 01/18/2007 | US20070014811 Agents For Treating Osteoporosis And Inhibiting Osteoclast Formation |
| 01/18/2007 | US20070014809 B Cell Activation and Polypeptides Having CD14 Activity |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy |
| 01/18/2007 | CA2615118A1 Pharmaceutical composition containing ppar.gamma. agonist |
| 01/18/2007 | CA2615028A1 Cross-.beta. structure binding compounds |
| 01/18/2007 | CA2614688A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/18/2007 | CA2614544A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2613976A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743901A2 Oligonucleotides having A-DNA or B-DNA form |
| 01/17/2007 | EP1743895A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 01/17/2007 | EP1743891A1 Heterocyclic compounds and methods for modulating CXCR3 function |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1743884A1 Progrugs to d-prolines |
| 01/17/2007 | EP1743655A1 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/17/2007 | EP1743653A1 Composition for increasing body height |
| 01/17/2007 | EP1743650A2 Feline intrerferon against feline atopic dermatitis |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743645A1 Adhesive patch |
| 01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742938A1 Preparation of candesartan cilexetil in high purity |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742925A1 Substituted 5, 6, 7, 8-tetrahydro-pyrido[4, 3-d]pyrimidine-2-yl compounds and 5, 6, 7, 8-tetrahydro-quinazoline-2-yl compounds |
| 01/17/2007 | EP1719524A9 Nuclear transfer promoter for rac protein and method of screening the same |
| 01/17/2007 | EP1537110B1 Triazospiro compounds having nociceptin receptor affinity |
| 01/17/2007 | EP1482925B1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 01/17/2007 | EP1453852B1 Selective urokinase inhibitors |
| 01/17/2007 | EP1450762B1 Novel formulation |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1345900B1 Guanidine and amidine derivatives as factor xa inhibitors |
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | EP1228232B1 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
| 01/17/2007 | EP1063990B1 Use of a biochanin-enriched extract for the treatment of estrogen-associated disorders |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | CN1898221A Modulators of atp-binding cassette transporters |
| 01/17/2007 | CN1897973A Propagation agent and propagation method for natural killer cell |
| 01/17/2007 | CN1896216A Wine and its brewing method |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1896045A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 01/17/2007 | CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 01/17/2007 | CN1895647A Health-care product based on natural aromatic composition |
| 01/17/2007 | CN1895590A Antong beverage |
| 01/17/2007 | CN1895570A Chinese medicinal composition pig growth |
| 01/17/2007 | CN1895569A Chinese-medicinal composition for improving fleece animal growth |
| 01/17/2007 | CN1895550A Medicine for treating hernia and its preparation |
| 01/17/2007 | CN1895539A Antong electruary |
| 01/17/2007 | CN1895523A Oral liquid for regulating gene nuclear energy and nucleic acid and its preparation |
| 01/17/2007 | CN1895514A Medicine for treating behcet's syndrome |
| 01/17/2007 | CN1895460A Hair-softening beverage |
| 01/17/2007 | CN1895449A Hair-blackening electuary |
| 01/17/2007 | CN1895432A Summerheat-dispelling beverage |
| 01/17/2007 | CN1895421A Chinese animal medicine for improving fowl growth |
| 01/17/2007 | CN1895369A Domestic Chinese-herb insect-repellent growth |
| 01/17/2007 | CN1895351A Chinese medicinal composition for treating poliosis and its making method |
| 01/17/2007 | CN1895334A Health-care medicine against brain fatigue |
| 01/17/2007 | CN1895328A Use of persimmon-plant material in preparation of oxygen-tolerent and anti-fatigue composition |
| 01/17/2007 | CN1895326A Sea-buckthorn particle electuary for improving micro-circulation and preventing diseases |
| 01/17/2007 | CN1895315A Active ginseng crisp and its preparation |
| 01/17/2007 | CN1895270A Anoxia and fatigue-resisting health-care oxygen, its preparation and use as health-care product |
| 01/17/2007 | CN1895265A Active medicinal matter for improving adrenal cortex hormone function prepared by coarse solomon's seal polysaccharide |
| 01/17/2007 | CN1295242C 3'-prodrugs of 2'-deoxy-beta-L-nucleosides |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295215C New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use |
| 01/17/2007 | CN1294989C Composition of nanometer SOD and nano pueraria root and its preparation method |
| 01/17/2007 | CN1294960C Anti-senescence bee medicine health care preparation |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163952 Azole compound and medicinal use thereof |
| 01/16/2007 | US7163929 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/16/2007 | US7163921 Peptide derivatives and medicinal compositions |